Top Abstract Purchase Related
Home
>
Node
>
Subnode

Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications

Agarwal, S.K.

Journal of Reproductive Medicine 43(3 Suppl): 293-298

1998

ISSN/ISBN: 0024-7758
PMID: 9564664
Document Number: 487564
OBJECTIVE: To understand why differences in gonadotropin releasing hormone (GnRH) agonist therapeutic protocols may affect their efficacy and safety profiles, to understand the important study design facets regarding the literature on GnRH agonist treatment of endometriosis and to compare the efficacy and side effect profiles of FDA-approved GnRH agonist therapies used for the management of endometriosis and consider the implications. STUDY DESIGN: Review of the English-language literature regarding the use of GnRH agonists for the management of endometriosis. RESULTS: A limited number of studies are available that directly compare the effects of different GnRH agonists. However, contrary to medical opinion, it appears that there are significant differences between GnRH agonist therapies. CONCLUSION: The data suggest that it may be possible to reduce doses or alter regimens of GnRH agonists so as to reduce side effects while maintaining efficacy.

Document emailed within 1 workday
Secure & encrypted payments

Grigoriadis, C.; Papaconstantinou, E.; Mellou, A.; Hassiakos, D.; Liapis, A.; Kondi-Pafiti, A. 2012: Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy Clinical and Experimental Obstetrics and Gynecology 39(2): 191-194
Agarwal, S.K. 2002: Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density? Journal of Reproductive Medicine 47(7): 530-534
Kim, C.-H.; Jeon, G.-H.; Cheon, Y.-P.; Jeon, I.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2009: Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection Fertility and Sterility 92(5): 1758-1760
Tanaka, T. 2007: Long-term personalized GnRH agonist therapy without estrogen supplementation for recurrent endometriotic catamenial pneumothorax--case report Clinical and Experimental Obstetrics and Gynecology 34(3): 179-181
Kuber, W.; Treu, T.; Kratzik, C.; Girsch, E.; Zeillinger, R.; Spona, J. 1990: Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies Wiener Klinische Wochenschrift 102(21): 640-647
Römer, T. 1998: The value of GnRH agonist treatments before hysteroscopic septum dissection Zentralblatt für Gynakologie 120(1): 42-44
Leonov, B.V.; Lukin, V.A.; Moskalenko, N.V.; Lazarev, A.P.; Pulina, G.A.; Khil'kevich, L.V.; Iavorovskaia, K.A. 1990: Use of decapeptyl (GnRH agonist) in the program of in vitro fertilization Akusherstvo i Ginekologiia 1990(1): 48-51
Gudmundsson, J.A.; Nillius, S.J.; Bergquist, C. 1984: Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH Contraception 30(2): 107-114
De Falco, M.; Pollio, F.; Pontillo, M.; Ambrosino, E.; Busiello, A.; Carbone, I.F.; Ciociola, F.; Di Nardo, M.A.; Landi, L.; Di Lieto, A. 2006: GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review Minerva Ginecologica 58(6): 553-560
Khonelidze, N.; Tsagareishvili, G.; Koiava, M.; Osidze, K. 2005: The use of gonadotropin-releasing hormone agonist (GnRH-a) dipherelin 3,75 mg for in vitro fertilization program Georgian Medical News 2005(121): 19-22
Weinbauer, G.F.; Nieschlag, E. 1989: Reversibility of GnRH agonist-induced inhibition of testicular function: differences between rats and primates Progress in Clinical and Biological Research 303: 75-87
Birnie, L.M.; Broadbent, P.J.; Hutchinson, J.S. 1997: Failure of prostaglandin F2 alpha analogue to induce luteolysis in GnRH agonist treated heifers Veterinary Record 140(12): 315
Scott, R.T.; Beatse, S.N.; Illions, E.H.; Snyder, R.R. 1995: Use of the GnRH agonist stimulation test in the diagnosis of ovarian remnant syndrome. A report of three cases Journal of Reproductive Medicine 40(2): 143-146
Yang, J.H.; Wu, M.Y.; Chao, K.H.; Chen, S.U.; Ho, H.N.; Yang, Y.S. 1997: Long GnRH-agonist protocol in an IVF program. Is it appropriate for women with normal FSH levels and high FSH/LH ratios? Journal of Reproductive Medicine 42(10): 663-668
Simon, A.; Birkenfeld, A.; Schenker, J.G. 1990: Gonadotropin releasing hormone (GnRH): mode of action and clinical applications. a review International Journal of Fertility 35(6): 350-362
Karimi-Zarchi, M.; Forat-Yazdi, M.; Vafaeenasab, M.R.; Nakhaie-Moghadam, M.; Miratashi-Yazdi, A.; Teimoori, S.; Dehghani-Tafti, A. 2014: Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide European Journal of Gynaecological Oncology 35(1): 59-61
Olivennes, F. 2004: Déclenchement par agonistes de la GnRH ou hCG et soutien de la phase lutéale dans les cycles sous antagonistes de la GnRH - Onset and maintenance of the luteal phase with GnRH antagonists or hCG in cycles under GnRH antagonists Journal de Gynecologie Obstetrique et Biologie de la Reproduction 33(6): 3S 24-3S 26
Goericke-Pesch, S.; Georgiev, P.; Antonov, A.; Vodenicharov, A.; Navarro, C.; Wehrend, A. 2014: Reversibility of germinative and endocrine testicular function after long-term contraception with a GnRH-agonist implant in the tom-a follow-up study Theriogenology 81(7): 941-946
Bode, M. 2009: Dopamine agonist therapy in early Parkinson's disease. a survey of a Cochrane review Ugeskrift for Laeger 171(41): 2996-2999
Litvintsev, S.V.; Reznik, A.M.; Arbuzov, A.L.; Barkov, D.A. 2002: Clopixol: new possibilities in therapy of mental disorders (a review of clinical studies) Voenno-Meditsinskii Zhurnal 323(3): 42-47